A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological response. (Q42984537)
Jump to navigation
Jump to search
scientific article published on March 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological response. |
scientific article published on March 2009 |
Statements
A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological response (English)
Hiromitsu Kumada
Fumitaka Suzuki
Kenji Ikeda
Masahiro Kobayashi
Yoshiyuki Suzuki
Norio Akuta
Yasuji Arase
Hitomi Sezaki
Satoshi Saitoh
Yusuke Kawamura
Mariko Kobayashi
Miharu Hirakawa